Evidence map›Paper›PMID 28031488›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

CD74 is a novel transcription regulator.

Naama Gil-Yarom, Lihi Radomir, Lital Sever, Matthias P Kramer, Hadas Lewinsky, Chamutal Bornstein, Ronnie Blecher-Gonen, Zohar Barnett-Itzhaki, Vita Mirkin, Gilgi Friedlander and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Pathogenic role of MIF receptor (CD74) expressing T cells in inflammatory arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. MSCA-Net: Multi-Modal Cell Segmentation for Spatial Transcriptomics.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  8. Structural insights into human signal peptide peptidase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Naama Gil-YaromDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Lihi RadomirDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Lital SeverDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Matthias P KramerDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0002-0289-5261
Hadas LewinskyDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Chamutal BornsteinDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Ronnie Blecher-GonenDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Zohar Barnett-ItzhakiDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Vita MirkinHematology Institute, Kaplan Medical Center, Rehovot 76100, Israel.
Gilgi FriedlanderNancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 76100, Israel.
Lev ShvidelHematology Institute, Kaplan Medical Center, Rehovot 76100, Israel.
Yair HerishanuDepartment of Hematology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Elias J LolisDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06510.
Shirly Becker-HermanDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Ido AmitDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Idit ShacharDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel; idit.shachar@weizmann.ac.il.
Weizmann Institute of Science · ILKaplan Medical Center · ILTel Aviv University · ILYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

CD74 is a cell-surface receptor for the cytokine macrophage migration inhibitory factor. Macrophage migration inhibitory factor binding to CD74 induces its intramembrane cleavage and the release of its cytosolic intracellular domain (CD74-ICD), which regulates cell survival. In the present study, we characterized the transcriptional activity of CD74-ICD in chronic lymphocytic B cells. We show that following CD74 activation, CD74-ICD interacts with the transcription factors RUNX (Runt related transcription factor) and NF-κB and binds to proximal and distal regulatory sites enriched for genes involved in apoptosis, immune response, and cell migration. This process leads to regulation of expression of these genes. Our results suggest that identifying targets of CD74 will help in understanding of essential pathways regulating B-cell survival in health and disease.

Indexed as

CD74CLLNF-κBRUNXtranscription

Identifiers

PMID28031488
PMCPMC5255621
OpenAlexW2566236348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.